Two Sigma Advisers
IMCR icon

Two Sigma Advisers’s Immunocore IMCR Stock Holding History

Two Sigma Advisers’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-322,300
Closed -$11.2M – 1031
2025
Q4 		$11.2M Sell
322,300
-7,700
-2% -$272K 0.02% 500
2025
Q3 		$12M Sell
330,000
-182,430
-36% -$6.2M 0.02% 450
2025
Q2 		$16.1M Sell
512,430
-10,970
-2% -$341K 0.03% 380
2025
Q1 		$15.5M Sell
523,400
-81,500
-13% -$2.44M 0.04% 400
2024
Q4 		$17.8M Sell
604,900
-152,800
-20% -$4.83M 0.04% 345
2024
Q3 		$23.6M Buy
757,700
+300,200
+66% +$10.9M 0.06% 287
2024
Q2 		$15.5M Buy
457,500
+370,900
+428% +$18.9M 0.03% 403
2024
Q1 		$5.63M Sell
86,600
-800
-0.9% -$54.9K 0.01% 733
2023
Q4 		$5.97M Sell
87,400
-22,100
-20% -$1.15M 0.01% 730
2023
Q3 		$5.68M Sell
109,500
-100
-0.1% -$5.92K 0.01% 674
2023
Q2 		$6.57M Buy
109,600
+90,700
+480% +$5.18M 0.02% 648
2023
Q1 		$934K Buy
+18,900
New +$1.06M ﹤0.01% 1668

Other funds holding IMCR

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Two Sigma Advisers's IMCR Position: Q1 2026 in Review

Two Sigma Advisers sold out of Immunocore (IMCR) in Q1 2026, closing a stake of 322,300 shares — an estimated $11.2M sold.

Two Sigma Advisers first reported a position in IMCR in Q1 2023 and held it in 12 quarters. The position peaked at $23.6M in Q3 2024. 142 funds tracked by Wall St. Rank hold IMCR as of Q1 2026.

  • Two Sigma Advisers reported no remaining Immunocore position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 322,300 Immunocore shares in Q1 2026, an estimated $11.2M.
  • Two Sigma Advisers first reported a position in Immunocore in Q1 2023 and held it in 12 quarters.
  • Two Sigma Advisers's Immunocore position peaked at $23.6M in Q3 2024.
  • 142 funds tracked by Wall St. Rank held Immunocore as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.